Trade

with

Oculus Innovative Sciences Inc
(NASDAQ: OCLS)
AdChoices
2.00
+0.04
+1.89%
After Hours :
1.85
-0.15
-7.36%

Open

1.92

Previous Close

1.96

Volume (Avg)

62.35k (59.95k)

Day's Range

1.80-2.02

52Wk Range

1.66-7.21

Market Cap.

16.93M

Dividend Rate ( Yield )

-

Beta

1.03

Shares Outstanding

8.48M

P/E Ratio (EPS)

2.72 (0.73)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 13.67M

    • Net Income

    • 3.74M

    • Market Cap.

    • 16.93M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 39.28

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.03

    • Forward P/E

    • -4.26

    • Price/Sales

    • 1.05

    • Price/Book Value

    • 1.24

    • Price/Cash flow

    • -2.48

      • EBITDA

      • 5.08M

      • Return on Capital %

      • 35.31

      • Return on Equity %

      • 67.12

      • Return on Assets %

      • 35.31

      • Book Value/Share

      • 1.58

      • Shares Outstanding

      • 8.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 7.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.46

        • Cashflow Estimate

        • 0.11

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.60

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 20.46

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 59.20

            • 64.72

            • Pre-Tax Margin

            • 39.28

            • 13.77

            • Net Profit Margin

            • 39.28

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 63.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -53.10

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.33

              • Current Ratio

              • 1.52

              • 1.52

              • Quick Ratio

              • 1.22

              • 0.87

              • Interest Coverage

              • 7.63

              • 6.77

              • Leverage Ratio

              • 1.48

              • 1.91

              • Book Value/Share

              • 1.58

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 2.39

                • 63.69

                • P/E Ratio 5-Year High

                • 30.54

                • 237.47

                • P/E Ratio 5-Year Low

                • 2.26

                • 19.71

                • Price/Sales Ratio

                • 0.94

                • 3.64

                • Price/Book Value

                • 1.11

                • 3.39

                • Price/Cash Flow Ratio

                • -2.48

                • 21.79

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 67.12

                    (-495.20)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 35.31

                    (-63.90)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 70.97

                    (-112.90)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 52.72k

                  • 27.79k

                  • Inventory Turnover

                  • 5.27

                  • 1.80

                  • Asset Turnover

                  • 0.90

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -6.05M
                  Operating Margin
                  -44.27
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -2.48
                  Ownership

                  Institutional Ownership

                  15.44%

                  Top 10 Institutions

                  17.35%

                  Mutual Fund Ownership

                  3.23%

                  Float

                  99.70%

                  5% / Insider Ownership

                  36.71%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    145,980

                  • 0.00

                  • 1.72

                  • Vanguard Extended Market Index Fund

                  •  

                    76,561

                  • 0.00

                  • 0.90

                  • Vanguard Instl Total Stock Market Index

                  •  

                    23,597

                  • 0.00

                  • 0.28

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    18,447

                  • 0.00

                  • 0.22

                  • Perkins Discovery Fund

                  •  

                    7,142

                  • 0.00

                  • 0.08

                  • Fidelity® Nasdaq Composite Tr Stk Fund

                  •  

                    886

                  • 9.38

                  • 0.01

                  • Dimensional US Sm Company

                  •  

                    371

                  • 0.00

                  • 0.00

                  • Vanguard US Equity Index

                  •  

                    342

                  • 0.00

                  • 0.00

                  • Wilshire 5000 Index Portfolio

                  •  

                    128

                  • 0.00

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Sabby Management LLC

                  •  

                    495,800

                  • -86.62%

                  • 6.85

                  • Vanguard Group, Inc.

                  •  

                    246,480

                  • 0.00%

                  • 2.91

                  • National Asset Management, Inc.

                  •  

                    43,253

                  • -19.68%

                  • 0.51

                  • Geode Capital Management, LLC

                  •  

                    19,257

                  • -0.20%

                  • 0.23

                  • Bard Associates Inc

                  •  

                    19,184

                  • -90.25%

                  • 0.23

                  • Perkins Capital Management Inc

                  •  

                    7,142

                  • 0.00%

                  • 0.08

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  Oculus Innovative Sciences Inc was incorporated under the laws of the State of California in April 1999 as Micromed Laboratories, Inc. In August 2001, it changed its name to Oculus Innovative Sciences, Inc. In December 2006, it reinc...moreorporated under the laws of the State of Delaware. The Company develops, manufactures and markets a family of tissue care products that cure infections and, through a separate mechanism of action, enhance healing while reducing the need for antibiotics. Infection is a serious potential complication in both chronic and acute wounds, and controlling infection is a critical step in wound healing. The Company’s platform technology, called Microcyn(r), is a proprietary solution of electrically charged oxychlorine small molecules designed to treat a wide range of organisms tha...moret cause disease (pathogens). These include viruses, fungi, spores and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus, or MRSA, and vancomycin-resistant Enterococcus, or VRE, in wounds, as well as Clostridium difficile (C. diff), a highly contagious bacteria spread by human contact. The Company’s products compete with a variety of products used for wound cleaning, debriding and moistening, including sterile saline, and chlorhexadine-based products, and they also compete with a large number of prescription and over-the-counter products for the prevention and treatment of infections, including topical anti-infectives, such as Betadine, silver sulfadiazine, hydrogen peroxide, Dakin’s solution and hypochlorous acid, and topical antibiotics, such as Neosporine, Mupirocin and Bacitracin. Government authorities in the United States at the federal, state and local levels and foreign countries extensively regulate, among other things, the research, development, testing, manufacture, labeling, promotion, advertising, distribution, sampling, marketing, and import and export of pharmaceutical products, biologics and medical devices.lessless

                  Key People

                  Mr. James Schutz

                  CEO/Director/President

                  Mr. Robert Miller

                  CFO/COO/Chief Accounting Officer/Secretary

                  Bruce Thornton

                  Executive VP, Divisional

                  Dr. Jay Edward Birnbaum

                  Director

                  Sharon Surrey-Barbari

                  Director

                  • Oculus Innovative Sciences Inc

                  • 1129 North McDowell Boulevard

                  • Petaluma, CA 94954

                  • USA.Map

                  • Phone: +1 707 283-0550

                  • Fax: +1 708 283-0551

                  • oculusis.com

                  Incorporated

                  1999

                  Employees

                  102

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: